Monday, June 15, 2026

How JNPMEDI Plans to Achieve 250% Revenue Growth in 2026: A Guide for Pharma Innovators

JNPMEDI aims to enhance its global role in drug and medical device development, achieving significant growth and expanding partnerships.

ATEEZ Sets New Standards in K-Pop with Chart-Topping Success Across Europe and Asia

According to an article previewing Billboard rankings, ATEEZ's 10th mini-album has secured the second spot on the Billboard 200.

Forget The Nuke: Kim Jong Un’s Biggest Threat Is A Matchbox Held By A Starving Farmer

North Korea warns of increased forest fire risk due to below-average rainfall and urges vigilance in fire prevention measures.

Tag: Regeneron

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Top News

- Our Sponsors Ad -

Follow us